Pedder Simon Insider Trades

Insider Trading History

Track insider trading activity for Pedder Simon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Athenex
Athenex ATNX
See Remarks
Holding Value $6.09k 30,000 shares
Last Trade
Aug 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.56M 60,000 shares
$76.00
$0.20
Athenex
Athenex ATNX
See Remarks
Holding Value $12.2k 60,000 shares
Last Trade
Jun 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.9M 60,000 shares
$249.00
$0.20
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of The Bd
Holding Value $3.32M 241,833 shares
Last Trade
Apr 09, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$53.7k 20,901 shares
$2.57
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of The Bd
Holding Value $3.61M 262,734 shares
Last Trade
Aug 27, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.1k 6,734 shares
$2.98
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of The Bd
Holding Value $1.61k 117 shares
Last Trade
Jun 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636 117 shares
$5.44
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of The Bd
Holding Value $4.12M 300,000 shares
Last Trade
May 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.74M 550,000 shares
$4.98
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of The Bd
Holding Value $82.4k 6,000 shares
Last Trade
May 14, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.4k 6,000 shares
$5.06
$13.74
Athenex
Athenex ATNX
See Remarks
Holding Value $1.08k 5,310 shares
Last Trade
Apr 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$327k 1,402 shares
$233.40
$0.20
Avalo Therapeutics
Avalo Therapeutics AVTX
Executive Chairman Of Board
Holding Value $4.12M 300,000 shares
Last Trade
Apr 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 300,000 shares
$5.17
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $12.1k 882 shares
Last Trade
Mar 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.15k 882 shares
$5.84
$13.74
Athenex
Athenex ATNX
See Remarks
Holding Value $12.2k 60,000 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.8M 60,000 shares
$263.40
$0.20
Delcath Systems
Delcath Systems DCTH
Director
Holding Value $1.03M 100,000 shares
Last Trade
Feb 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.99k 100,000 shares
$0.10
$10.33
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $20.7k 1,504 shares
Last Trade
Dec 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86k 1,504 shares
$3.23
$13.74
Athenex
Athenex ATNX
See Remarks
Holding Value $794 3,908 shares
Last Trade
Nov 14, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$596k 2,908 shares
$204.90
$0.20
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $13.6k 990 shares
Last Trade
Sep 28, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.62k 990 shares
$4.67
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $13.9k 1,012 shares
Last Trade
Jun 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.39k 1,012 shares
$4.34
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $115k 8,357 shares
Last Trade
May 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 8,357 shares
$3.71
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $230k 16,714 shares
Last Trade
Apr 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.2k 16,714 shares
$4.14
$13.74
Athenex
Athenex ATNX
See Remarks
Holding Value $12.2k 60,000 shares
Last Trade
Mar 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8M 60,000 shares
$346.00
$0.20
Athenex
Athenex ATNX
See Remarks.
Holding Value $26.4k 130,000 shares
Last Trade
Jun 19, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.8M 130,000 shares
$290.40
$0.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up